Evolent Health, Inc. (EVH) › Cash & EquivalentsEvolent Health, Inc. (EVH) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $5.25M2013: $02014: $02015: $145.73M2016: $134.56M2017: $238.43M2018: $228.32M2019: $101.01M2020: $319.00M2021: $266.28M2022: $188.20M2023: $192.82M2024: $104.20M2025: $151.86M$151.86M2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$151.86M+45.7%2024$104.20M-46.0%2023$192.82M+2.5%2022$188.20M-29.3%2021$266.28M-16.5%2020$319.00M+215.8%2019$101.01M-55.8%2018$228.32M-4.2%2017$238.43M+77.2%2016$134.56M-7.7%2015$145.73M—2014$0—2013$0-100.0%2012$5.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share